Cold-cough

Commercial

Portfolio-7447-for-WEB

NCE Pipeline

Discovery-7447-for-WEB

Research

Latest Annual Report

Vernalis-AR2013-CoverApr 01, 2014

2013 Results Download our latest report...        


Archive

Latest Presentation

ceoMay 1, 2015

Our latest presentation is available to view here...


Archive

Share Price

Share price:  67.63p
Change:  1.88 (2.85%)
As at:  22 May 2015 18:15:01
Volume:  284,680
LSE ID:  VER

Share price details

Latest News

Vernalis and Tris Pharma receive FDA approval of NDA for Tuzistra™ XR (codeine polistirex and chlorpheniramine polistirex)

Vernalis plc and Tris Pharma Inc. today announce that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application

Read more...

At a glance

More information on Vernalis and it's pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form